| 规格: | 98% |
| 分子量: | 313.4 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Background:
TLR7/8 agonist 3 is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II))[1].
[1]. Martha A. MILLER, et al. Vaccine compositions and methods of use to treat neonatal subjects.
m.cnreagent.com